Testing a new drug's interaction in healthy adults
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests how a new drug (JMKX003142) interacts with other substances in healthy volunteers. It helps researchers understand how the drug is absorbed and processed, which is a key step before it can be tested in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old.
- Be in good general health with no major medical conditions.
- Have a BMI between 19 and 28 (a healthy weight range).
- Men must weigh at least 50 kg (110 pounds), women at least 45 kg (99 pounds).
- Be willing to follow the study diet and give up smoking (if you smoke) during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for healthy volunteers to see how a new experimental drug (JMKX003142) interacts with other drugs in the body. It helps find the right dose for future patients.
This study looks at how a new drug (JMKX003142) is absorbed and broken down in the body. It involves healthy men and will help determine safe dosing for future studies.
This study tests a new medicine (JMKX003142) in healthy adults to see if it affects the heart's rhythm. If you qualify, you may help determine whether the drug is safe to use in future patients.
This trial tests a drug (JMKX003142) for people with autosomal dominant polycystic kidney disease that is getting worse quickly. It may help slow down kidney damage.
This study tests a new investigational drug called GV-100 to see how safe it is and how the body handles it. It is for healthy adults and will be given in different doses to find the best one.
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
Hear when a new ADPKD (autosomal Dominant Polycystic Kidney Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.